FDA Launches ‘Snap Shot’ on Clinical Trial Subgroup Data

Drug Industry Daily
A A
As part of an initiative to increase clinical trial transparency, the FDA has launched a website that provides information about the sex, age, race and ethnicity of participants in studies that support drug approvals.

To View This Article:

Login

Subscribe To Drug Industry Daily